Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain **Supported in part by a grant from Syntex Laboratories, Inc., Palo Alto, California.††Presented in part at the 48th Annual Meeting of The American Fertility Society, New Orleans, Louisiana, November 2 to 5, 1992.-Reference-Cited by-同舟云学术

Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain **Supported in part by a grant from Syntex Laboratories, Inc., Palo Alto, California.††Presented in part at the 48th Annual Meeting of The American Fertility Society, New Orleans, Louisiana, November 2 to 5, 1992.

Published:1995-05 Issue:5 Volume:63 Page:955-962
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Hornstein Mark D.,Yuzpe A. Albert,Burry Kenneth A.,Heinrichs Le Roy,Buttram Veasy L.,Orwoll Eric S.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference17 articles.

1. “Medical oophorectomy” using a long-acting GnRH agonist—a possible new approach to the treatment of endometriosis;Meldrum;J Clin Endocrinol Metab,1982

2. Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist;Lemay;Fertil Steril,1982

3. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin);Schriock;Fertil Steril,1985

4. Administration of nasal nafarelin as compared with oral danazol for endometriosis—a multicenter double-blind comparative clinical trial;Henzl;N Engl J Med,1988

5. A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis;Tummon;Fertil Steril,1989

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action;Pain;2024-07-02

2. Gonadotropin-releasing hormone analogues for endometriosis;Cochrane Database of Systematic Reviews;2023-06-21

3. Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?;Human Reproduction Open;2023-01-01

4. Medical Treatments of Endometriosis: A Review;Reproductive and Developmental Medicine;2022-11-09

5. GnRH agonists in the treatment of symptomatic endometriosis: a review;F&S Reports;2022-11